Prevalence and Risk Factors of Thromboembolic Events in Dermatomyositis in China: A 10-Year Retrospective Analysis
Liubing Li, Tangdan Ding, Qiong Shi, Hongji Zhu, Qinghua Ma, Mianjing Zhou, Ying Yuan, Zhihua Wen, Hongxu Xu, Hongxia Tan, Dubo Chen · 2024
Read Prevalence and Risk Factors of Thromboembolic Events in Dermatomyositis in China: A 10-Year Retrospective Analysis by Liubing Li, Tangdan Ding, Qiong Shi, Hongji Zhu, Qinghua Ma, Mianjing Zhou, Ying Yuan, Zhihua Wen, Hongxu Xu, Hongxia Tan, Dubo Chen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11600963.txt.
Description
Liubing Li and co-authors count blood clot events among patients with dermatomyositis in China over ten years. Their 2024 study reviews 543 hospitalized patients with this autoimmune muscle disease. People with the condition face higher clot risk, but the size of that risk and its drivers were unclear.
Twenty-two patients, about four percent, had clotting events, split between vein and artery types. Steroid therapy strongly protected against clots, while high D-dimer blood levels raised the risk. Together the two factors sorted patients with striking accuracy. The authors advise screening patients who never had steroids and whose D-dimer runs high, so clots can be caught early.
Catalog record
| CREATOR | Liubing Li, Tangdan Ding, Qiong Shi, Hongji Zhu, Qinghua Ma, Mianjing Zhou, Ying Yuan, Zhihua Wen, Hongxu Xu, Hongxia Tan, Dubo Chen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |